News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,959 Results
Type
Article (61867)
Company Profile (465)
Press Release (658627)
Section
Business (195621)
Career Advice (3496)
Deals (35370)
Drug Delivery (124)
Drug Development (85070)
Employer Resources (177)
FDA (17344)
Job Trends (15474)
News (343601)
Policy (34790)
Tag
Academia (2909)
Alliances (51413)
Alzheimer's disease (1422)
Approvals (17300)
Artificial intelligence (237)
Bankruptcy (352)
Best Places to Work (12229)
Biotechnology (350)
Breast cancer (246)
Cancer (1892)
Cardiovascular disease (150)
Career advice (2955)
CAR-T (147)
Cell therapy (422)
Clinical research (68244)
Collaboration (744)
Compensation (378)
COVID-19 (2762)
C-suite (186)
Data (1726)
Diabetes (241)
Diagnostics (6456)
Earnings (74296)
Employer resources (154)
Events (113983)
Executive appointments (612)
FDA (18325)
Funding (660)
Gene therapy (298)
GLP-1 (767)
Government (4837)
Healthcare (20024)
Infectious disease (2889)
Inflammatory bowel disease (138)
Interviews (686)
IPO (16506)
Job creations (3752)
Job search strategy (2413)
Layoffs (478)
Legal (7969)
Lung cancer (276)
Manufacturing (269)
Medical device (13520)
Medtech (13524)
Mergers & acquisitions (19279)
Metabolic disorders (647)
Neuroscience (1893)
NextGen: Class of 2025 (7179)
Non-profit (4882)
Northern California (2185)
Obesity (359)
Opinion (263)
Patents (181)
People (56848)
Phase I (21223)
Phase II (29959)
Phase III (22471)
Pipeline (810)
Postmarket research (2795)
Preclinical (9156)
Radiopharmaceuticals (264)
Rare diseases (372)
Real estate (5992)
Regulatory (23917)
Research institute (2588)
Resumes & cover letters (565)
Southern California (1898)
Startups (3719)
United States (19815)
Vaccines (707)
Weight loss (267)
Date
Today (117)
Last 7 days (826)
Last 30 days (2844)
Last 365 days (35996)
2025 (5667)
2024 (36863)
2023 (41472)
2022 (52683)
2021 (57296)
2020 (55909)
2019 (49201)
2018 (37325)
2017 (34532)
2016 (34400)
2015 (39512)
2014 (32436)
2013 (27959)
2012 (29566)
2011 (29960)
2010 (28316)
Location
Africa (1020)
Arizona (186)
Asia (43040)
Australia (7403)
California (5067)
Canada (1752)
China (429)
Colorado (231)
Connecticut (249)
Europe (97967)
Florida (740)
Georgia (169)
Illinois (521)
Indiana (277)
Maryland (783)
Massachusetts (3984)
Michigan (206)
Minnesota (349)
New Jersey (1449)
New York (1451)
North Carolina (961)
Northern California (2185)
Ohio (179)
Pennsylvania (1146)
South America (1350)
Southern California (1898)
Texas (734)
Utah (156)
Washington State (501)
720,959 Results for "the alliance for regenerative medicine arm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Veristat, the Science-First Full Service CRO and Consultancy, announced it has joined the Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of cell and gene therapies for patients, healthcare systems, and society.
April 3, 2024
·
3 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
September 27, 2024
·
8 min read
Business
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. and Minaris Regenerative Medicine Co., today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
June 20, 2024
·
6 min read
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
Press Releases
Doron Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MOTYS for Treatment of Symptoms Associated With Osteoarthritis
February 19, 2025
·
3 min read
Gene therapy
Patient Death in Rett Syndrome Trial Forces Neurogene to Drop High-Dose Arm
Despite the death, the FDA has allowed Neurogene to forge ahead with the Phase I/II Rett syndrome trial, but using only the lower 1E15 vg dose of its investigational gene therapy NGN-401.
November 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EXG-34217 for Treatment of Telomere Biology Disorders
February 14, 2025
·
2 min read
Press Releases
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
February 10, 2025
·
7 min read
Press Releases
Beacon Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for laru-zova (AGTC-501)
January 28, 2025
·
4 min read
1 of 72,096
Next
